Loading…
Ascendia Pharmaceutical Solutions
Accepting projectsYour Partner from Pre-formulation to Commercialization
Capabilities & focus
Process-development services
PreformulationFormulation developmentAnalytical method developmentClinical trial material manufacturing
Molecule types
Small molecule
Formulation
LNP encapsulationAmorphous solid dispersionNano-emulsion
Technology platforms
Four proprietarytrademarked nanotechnology platforms stated by the company: EmulSol (oil-in-water nano-emulsions)LipidSol (lipid nanoparticle technology)AmorSol (amorphous solid dispersion) and NanoSol (nano-sized drug particles)plus controlled-release technology. Equipment named on the site includes a NETZSCH Vakumix system for aseptic wet milling of nano-suspensions and a Precision NanoSystems NanoAssemblr GMP System for LNP manufacturing.
Private
Ownership
2012
Founded
ASC
Ascendia Pharmaceutical Solutions
Process development org · United States
Live record · illustrative seed data · scores deterministic, rules-based — not AI. Not a regulatory determination or endorsement.